Not available
Quote | KalVista Pharmaceuticals Inc. (NASDAQ:KALV)
Last: | $11.86 |
---|---|
Change Percent: | -0.09% |
Open: | $11.08 |
Close: | $11.86 |
High: | $12.4555 |
Low: | $10.92 |
Volume: | 2,152,839 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | KalVista Pharmaceuticals Inc. (NASDAQ:KALV)
2024-03-23 20:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– Delays in treating attacks lead to increased anxiety, quality of life issues, higher frequency of returning attacks, and suboptimal clinical outcomes in both on-demand and prophylaxis patients - KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical co...
Message Board Posts | KalVista Pharmaceuticals Inc. (NASDAQ:KALV)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $KALV hod6.24 | znewcar1 | investorshangout | 12/28/2022 7:21:21 PM |
I would not even buy the shares at $20. | Femto99 | investorshub | 02/11/2021 5:16:09 PM |
All in puts! | Femto99 | investorshub | 02/11/2021 4:02:31 PM |
znewcar1: KALV 114% v34,8M c33.50 f17,9M preMH51.3 HOD44.7 S28.9 | znewcar1 | investorshangout | 02/09/2021 9:17:38 PM |
Boom! Killed it with puts today! | Stock_Barber | investorshub | 02/09/2021 9:01:35 PM |
News, Short Squeeze, Breakout and More Instantly...
KalVista Pharmaceuticals Inc. Company Name:
KALV Stock Symbol:
NASDAQ Market:
KalVista Pharmaceuticals Inc. Website:
2024-03-23 20:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– Delays in treating attacks lead to increased anxiety, quality of life issues, higher frequency of returning attacks, and suboptimal clinical outcomes in both on-demand and prophylaxis patients - KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical co...
2024-03-13 18:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...